Old Mission Capital’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Old Mission Capital’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-20,424	Closed	-$1.19M	–	649
2020 Q2	$1.19M	Buy	+20,424	New	+$1.1M	0.09%	171

Other funds holding SYNH

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Old Mission Capital's SYNH Position: Q3 2020 in Review

Old Mission Capital sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2020, closing a stake of 20,424 shares — an estimated $1.19M sold.

Old Mission Capital first reported a position in SYNH in Q2 2020 and held it in 1 quarter. The position peaked at $1.19M in Q2 2020. 300 funds tracked by Wall St. Rank hold SYNH as of Q3 2020.

Old Mission Capital reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2020 after selling out during the quarter.
Old Mission Capital sold 20,424 Syneos Health, Inc. Class A Common Stock shares in Q3 2020, an estimated $1.19M.
Old Mission Capital first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2020 and held it in 1 quarter.
Old Mission Capital's Syneos Health, Inc. Class A Common Stock position peaked at $1.19M in Q2 2020.
300 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2020.

Based on Old Mission Capital's 13F filing for Q3 2020, filed 16 Nov 2020.